Report: U.S. Drug Channel Landscape Q1 2023

Featured image - Circana US Drug Channel report

Get the insight report!

In this report, Circana identifies trends occurring in the drug channel and compares activity in the drug channel to the broader multioutlet and convenience channel landscape.

Even as U.S. inflation is softening, consumers report financial anxiety as they are consolidating trips to value channels and spending cautiously.

In Q1 2023:

✅ Drug channel laps significant growth last year during COVID-19 vaccination-led traffic.
✅ Drug channel sales improved in Q1 2023 led by beauty, food & beverage and general merchandise.
✅ The drug channel has an opportunity to expand grab-and-go assortment for CPG products.

Don’t Miss Out on This Insightful Report on the Drug Channel!

Get access by filling out the form on the right.